Page last updated: 2024-08-23

daunorubicin and olomoucine ii

daunorubicin has been researched along with olomoucine ii in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ceckova, M; Cihalova, D; Hofman, J; Staud, F	1

Other Studies

1 other study(ies) available for daunorubicin and olomoucine ii

Article	Year
Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro. PloS one, 2013, Volume: 8, Issue:12 Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Gene Expression Regulation; Humans; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine	2013

Article

Year

Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro.

PloS one, 2013, Volume: 8, Issue:12

Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Gene Expression Regulation; Humans; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine

2013